BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2020 8:10:05 AM | Browse: 642 | Download: 1054
 |
Received |
|
2020-07-28 09:12 |
|
Peer-Review Started |
|
2020-07-28 09:13 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-09-30 03:07 |
|
Revised |
|
2020-10-11 14:55 |
|
Second Decision |
|
2020-11-02 12:15 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-11-04 04:35 |
|
Articles in Press |
|
2020-11-04 04:35 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-11-14 01:52 |
|
Typeset the Manuscript |
|
2020-12-10 02:08 |
|
Publish the Manuscript Online |
|
2020-12-14 08:10 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Bin-Bin Huang, Li-Chun Han, Geng-Feng Liu, Xiao-Dan Lv, Guang-Li Gu, Shi-Quan Li, Lan Chen, Hui-Qin Wang, Ling-Ling Zhan and Xiao-Ping Lv |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81860104 |
| National Natural Science Foundation of China |
81460114 |
| Natural Science Foundation of Guangxi Zhuang Autonomous Region |
2017GXNSFAA198299 |
| Development and Application of Medical and Health Appropriate Technology Project in Guangxi Zhuang Autonomous Region |
S2018049 |
| Youth Science Foundation of Guangxi Medical University |
GXMUYSF201913 |
| Youth Science Foundation of Guangxi Medical University |
GXMUYSF201908 |
| Self-financing Project of Health Commission of Guangxi Zhuang Autonomous Region |
Z20200398 |
|
| Corresponding Author |
Xiao-Ping Lv, MM, Chief Physician, Professor, Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. lxxp58@hotmail.com |
| Key Words |
Ulcerative colitis; Dermatomyositis; Extraintestinal manifestation; Infliximab; Mesalazine; Case report |
| Core Tip |
Few cases of ulcerative colitis have dermatomyositis (DM) as complication. DM may be a less frequent extraintestinal manifestation of ulcerative colitis. Infliximab is effective in the treatment of ulcerative colitis in patients with autoimmune disease or poor hormone response. |
| Publish Date |
2020-12-14 08:10 |
| Citation |
Huang BB, Han LC, Liu GF, Lv XD, Gu GL, Li SQ, Chen L, Wang HQ, Zhan LL, Lv XP. Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report. World J Gastroenterol 2020; 26(46): 7425-7435 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i46/7425.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i46.7425 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
